Impact of FDG PET Imaging for Expanding Patient Eligibility...

Clinical Cancer Research 2019 / 12 Vol. 25; Iss. 24

Impact of FDG PET Imaging for Expanding Patient Eligibility and Measuring Treatment Response in a Genome-Driven Basket Trial of the Pan-HER Kinase Inhibitor, Neratinib

Ulaner, Gary A., Saura, Cristina, Piha-Paul, Sarina A., Mayer, Ingrid, Quinn, David, Jhaveri, Komal, Stone, Ben, Shahin, Seta, Mann, Grace, Dujka, Melanie, Bryce, Richard, Meric-Bernstam, Funda, Solit
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
25
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-19-1658
Date:
December, 2019
File:
PDF, 598 KB
2019
Conversion to is in progress
Conversion to is failed